Vinati Organics Ltd Q1 FY19 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
No
Order
N/A
Capex
Yes
1 of 4 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 2- Vinati Organics expects overall sales growth at a CAGR of ~25% for the next 3 years.
- ATBS volumes are projected to grow by 25%-30% annually for the next 2-3 years, driven by capacity expansion from 26,000 to 40,000 tonnes by April 2019.
- Butylphenols plant to start by April 2019 with 60-65% capacity utilization in FY2020 and full utilization in FY2021, targeting Rs.350-400 Crores in sales.
- IBB volumes expected to grow around 15% in FY2020 after subdued growth in FY2019 due to customer shutdown.
- PAP project’s commercialization is uncertain; management excludes it from near-term projections.
- Continued focus on new products backed by R&D pipeline to sustain long-term growth.
See what Vinati Organics Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
No- Vinati Organics Limited does not plan to raise any debt for current or future projects.
- All future projects, including the PAP project, are expected to be funded entirely through internal accruals.
- The company currently has no debt on the books.
- Management aims to maintain a payout ratio of about 20%, reinvesting most cash flows back into the business to maximize returns.
- Cash flows for the current year are expected to be around Rs.400 Crores on Rs.1000 Crores revenues, indicating strong internal funding capability.
See what Vinati Organics Ltd management said on order book — free account, 30 seconds.
Capex plans
Yes- **ATBS Capacity Expansion:** Increasing from 26,000 to 40,000 tonnes; capex of Rs. 75-80 Crores, expected completion by April 2019.
- **Butylphenol Plant:** Investment of Rs. 240 Crores, expecting sales of Rs. 350-400 Crores; plant to come on stream by April 2019, ramping up to 65% utilization in first year and 100% subsequently.
- **PAP Project:** Pilot plant with Rs. 20 Crores investment; commercial decision pending successful pilot trials over next 3-6 months; potential major future project with estimated Rs. 600 Crores capex, 1:1 asset turnover, and 20% EBITDA margins.
- **Overall Capex Guidance:** Rs. 300 Crores for FY2019 mainly for butylphenols and ATBS expansion; FY2020 capex uncertain, dependent on PAP project.
- **Funding:** All future projects to be funded through internal accruals without additional debt; payout ratio maintained around 20%.
Track Vinati Organics Ltd — get its next earnings analysis in your feed
Margin guidance
Category 3- Vinati Organics expects profits to grow at 25%-30% annually over the next three years.
- EBITDA margins are anticipated to sustain around 35%, supported by high-margin ATBS volumes and stable product mix.
- The company projects a 25% volume growth in ATBS for the next two to three years due to increased capacity and market leadership.
- Butylphenol plant commissioning in April 2019 will ramp up sales to Rs.350-400 Crores, achieving 60%-65% capacity utilization in FY2020 and full utilization by FY2021.
- IBB volumes are expected to grow approximately 15% annually from FY2020, recovering from prior customer shutdowns and capacity expansion.
- PAP project is uncertain; management advises excluding PAP from near-term projections.
- Overall, business growth driven by existing products with new capacities and expansions support a robust earnings growth outlook.
Order book
- The transcript does not explicitly mention the current or expected order book or pending orders for Vinati Organics Limited.
- However, the company has highlighted strong demand and capacity utilization:
- - ATBS capacity is fully utilized at 26,000 tonnes with plans to expand to 40,000 tonnes by April 2019 due to strong market demand and exit of competitor Lubrizol.
- - IBB capacity has been expanded from 16,000 to 25,000 tonnes, catering to growing demand.
- - The butylphenol plant is expected to start by April 2019 with ramp-up over FY2020 and FY2021.
- The company expects growth driven by volume growth in ATBS and new customer additions.
- Capex plans include Rs. 75-80 Crores for ATBS expansion and Rs. 240 Crores for butylphenol plant.
- No specific order book figures or pending order details were provided in the call.
How does Vinati Organics Ltd rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Vinati Organics Ltd rank in Chemicals & Petrochemicals?
Compare Vinati Organics Ltd against every Chemicals & Petrochemicals company (Q1 FY19) on revenue, margins and earnings-call signals.
Continue your research
What Vinati Organics Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Ch. (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
- Deepak Fertilis. (Q1 FY27)
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…